{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:30:35Z","timestamp":1740148235312,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12094-020-02453-0","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T11:02:42Z","timestamp":1595847762000},"page":"591-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SMARCA4 promotes benign skin malignant transformation into melanoma through Adherens junction signal transduction"],"prefix":"10.1007","volume":"23","author":[{"given":"S.-R.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7575-5246","authenticated-orcid":false,"given":"Y.-Z.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"2453_CR1","first-page":"1","volume":"22","author":"M Situm","year":"2014","unstructured":"Situm M, Buljan M, Kolic M, Vucic M. Melanoma\u2013clinical, dermatoscopical, and histopathological morphological characteristics. Acta Dermatovenerol Croat. 2014;22:1\u201312.","journal-title":"Acta Dermatovenerol Croat"},{"key":"2453_CR2","doi-asserted-by":"publisher","first-page":"xv","DOI":"10.1016\/j.soc.2015.01.001","volume":"24","author":"AC Berger","year":"2015","unstructured":"Berger AC. Melanoma. Surg Oncol Clin N Am. 2015;24:xv\u2013xvi.","journal-title":"Surg Oncol Clin N Am"},{"key":"2453_CR3","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. Vivo. 2014;28:1005\u2013111.","journal-title":"Vivo"},{"key":"2453_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","volume":"53","author":"J Read","year":"2016","unstructured":"Read J, Wadt KA, Hayward NK. Melanoma genetics. J Med Genet. 2016;53:1\u201314.","journal-title":"J Med Genet"},{"key":"2453_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-22539-5_1","volume":"167","author":"B Shannan","year":"2016","unstructured":"Shannan B, Perego M, Somasundaram R, Herlyn M. Heterogeneity in melanoma. Cancer Treat Res. 2016;167:1\u201315.","journal-title":"Cancer Treat Res"},{"key":"2453_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pcmr.12661","volume":"31","author":"GM Fischer","year":"2018","unstructured":"Fischer GM, Vashisht Gopal YN, McQuade JL, Peng W, DeBerardinis RJ, Davies MA. Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications. Pigment Cell Melanoma Res. 2018;31:11\u201330.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2453_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10555-017-9661-5","volume":"36","author":"SA Leachman","year":"2017","unstructured":"Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, Ghiorzo P. Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev. 2017;36:77\u201390.","journal-title":"Cancer Metastasis Rev"},{"key":"2453_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","volume":"36","author":"O Abbas","year":"2014","unstructured":"Abbas O, Miller DD, Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol. 2014;36:363\u201379.","journal-title":"Am J Dermatopathol"},{"key":"2453_CR9","first-page":"7038579","volume":"2017","author":"X Chen","year":"2017","unstructured":"Chen X, Gao G, Liu S, Yu L, Yan D, Yao X, Sun W, Han D, Dong H. Long noncoding RNA PVT1 as a novel diagnostic biomarker and therapeutic target for melanoma. Biomed Res Int. 2017;2017:7038579.","journal-title":"Biomed Res Int"},{"key":"2453_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01.cco.0000154039.07466.5d","volume":"17","author":"S Torabian","year":"2005","unstructured":"Torabian S, Kashani-Sabet M. Biomarkers for melanoma. Curr Opin Oncol. 2005;17:167\u201371.","journal-title":"Curr Opin Oncol"},{"key":"2453_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10555-017-9657-1","volume":"36","author":"M Kunz","year":"2017","unstructured":"Kunz M, Holzel M. The impact of melanoma genetics on treatment response and resistance in clinical and experimental studies. Cancer Metastasis Rev. 2017;36:53\u2013755.","journal-title":"Cancer Metastasis Rev"},{"key":"2453_CR12","first-page":"1071","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi GC, Falzone L, Salemi R, Zanghi A, Spandidos DA, McCubrey JA, Candido S, Libra M. Cutaneous melanoma: from pathogenesis to therapy (Review). Int J Oncol. 2018;52:1071\u201380.","journal-title":"Int J Oncol"},{"key":"2453_CR13","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/S1470-2045(13)70333-4","volume":"15","author":"FB Bombelli","year":"2014","unstructured":"Bombelli FB, Webster CA, Moncrieff M, Sherwood V. The scope of nanoparticle therapies for future metastatic melanoma treatment. Lancet Oncol. 2014;15:e22\u201332.","journal-title":"Lancet Oncol"},{"key":"2453_CR14","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.21873\/anticanres.11221","volume":"36","author":"T Tang","year":"2016","unstructured":"Tang T, Eldabaje R, Yang L. Current status of biological therapies for the treatment of metastatic melanoma. Anticancer Res. 2016;36:3229\u2013411.","journal-title":"Anticancer Res"},{"key":"2453_CR15","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","volume":"11","author":"D Talantov","year":"2005","unstructured":"Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res. 2005;11:7234\u201342.","journal-title":"Clin Cancer Res"},{"key":"2453_CR16","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41:D991\u2013D99595.","journal-title":"Nucleic Acids Res"},{"key":"2453_CR17","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"2453_CR18","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29.","journal-title":"Genome Biol"},{"key":"2453_CR19","doi-asserted-by":"crossref","unstructured":"Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 3: Article3.","DOI":"10.2202\/1544-6115.1027"},{"key":"2453_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"2453_CR21","first-page":"1791","volume":"33","author":"W Liu","year":"2017","unstructured":"Liu W, Li L, Ye H, Tu W. Weighted gene co-expression network analysis in biomedicine research. Sheng Wu Gong Cheng Xue Bao. 2017;33:1791\u2013801.","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"2453_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"2453_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1634\/theoncologist.2015-0207","volume":"21","author":"MJ Xu","year":"2016","unstructured":"Xu MJ, Dorsey JF, Amaravadi R, Karakousis G, Simone CB 2nd, Xu X, Xu W, Carpenter EL, Schuchter L, Kao GD. Circulating tumor cells, DNA, and mRNA: potential for clinical utility in patients with melanoma. Oncologist. 2016;21:84\u201394.","journal-title":"Oncologist"},{"key":"2453_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejcb.2013.10.003","volume":"93","author":"M Kappelmann","year":"2014","unstructured":"Kappelmann M, Bosserhoff A, Kuphal S. AP-1\/c-Jun transcription factors: regulation and function in malignant melanoma. Eur J Cell Biol. 2014;93:76\u201381.","journal-title":"Eur J Cell Biol"},{"key":"2453_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.mie.2016.09.016","volume":"585","author":"G Pei","year":"2017","unstructured":"Pei G, Chen L, Zhang W. WGCNA application to proteomic and metabolomic data analysis. Methods Enzymol. 2017;585:135\u201358.","journal-title":"Methods Enzymol"},{"key":"2453_CR26","doi-asserted-by":"publisher","first-page":"e0190447","DOI":"10.1371\/journal.pone.0190447","volume":"13","author":"LX Wang","year":"2018","unstructured":"Wang LX, Li Y, Chen GZ. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma. PLoS ONE. 2018;13:e0190447.","journal-title":"PLoS ONE"},{"key":"2453_CR27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/bjc.2011.451","volume":"105","author":"F Journe","year":"2011","unstructured":"Journe F, Id Boufker H, Van Kempen L, Galibert MD, Wiedig M, Sales F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G. TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome. Br J Cancer. 2011;105:1726\u201332.","journal-title":"Br J Cancer"},{"key":"2453_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/bjc.2015.194","volume":"113","author":"P El Hajj","year":"2015","unstructured":"El Hajj P, Gilot D, Migault M, Theunis A, van Kempen LC, Sales F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F. SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma. Br J Cancer. 2015;113:91\u20138.","journal-title":"Br J Cancer"},{"key":"2453_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/CMR.0000000000000228","volume":"26","author":"HM Sheppard","year":"2016","unstructured":"Sheppard HM, Feisst V, Chen J, Print C, Dunbar PR. AHNAK is downregulated in melanoma, predicts poor outcome, and may be required for the expression of functional cadherin-1. Melanoma Res. 2016;26:108\u201316.","journal-title":"Melanoma Res"},{"key":"2453_CR30","first-page":"5356737","volume":"2017","author":"X Wan","year":"2017","unstructured":"Wan X, Liu R, Li Z. The prognostic value of HRAS mRNA expression in cutaneous melanoma. Biomed Res Int. 2017;2017:5356737.","journal-title":"Biomed Res Int"},{"key":"2453_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biocel.2014.11.015","volume":"59","author":"CK Hind","year":"2015","unstructured":"Hind CK, Carter MJ, Harris CL, Chan HT, James S, Cragg MS. Role of the pro-survival molecule Bfl-1 in melanoma. Int J Biochem Cell Biol. 2015;59:94\u2013102.","journal-title":"Int J Biochem Cell Biol"},{"key":"2453_CR32","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1242\/jcs.115204","volume":"125","author":"EA Craig","year":"2012","unstructured":"Craig EA, Weber JD, Spiegelman VS. Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia. J Cell Sci. 2012;125:5950\u20134.","journal-title":"J Cell Sci"},{"key":"2453_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/ijms18030532","volume":"18","author":"EJ Park","year":"2017","unstructured":"Park EJ, Lee YM, Oh TI, Kim BM, Lim BO, Lim JH. Vanillin suppresses cell motility by inhibiting STAT3-mediated HIF-1alpha mRNA expression in malignant melanoma cells. Int J Mol Sci. 2017;18:532.","journal-title":"Int J Mol Sci"},{"key":"2453_CR34","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1158\/1078-0432.CCR-13-2906","volume":"20","author":"Y Saenger","year":"2014","unstructured":"Saenger Y, Magidson J, Liaw B, de Moll E, Harcharik S, Fu Y, Wassmann K, Fisher D, Kirkwood J, Oh WK, Friedlander P. Blood mRNA expression profiling predicts survival in patients treated with tremelimumab. Clin Cancer Res. 2014;20:3310\u20138.","journal-title":"Clin Cancer Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02453-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02453-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02453-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:30:48Z","timestamp":1627345848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02453-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02453-0","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Ethical Committee of The Second Hospital of Jilin University and conducted in accordance with the ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}